Wednesday, April 1, 2026

Why Did Space Stocks Go Up When Artemis Kept Getting Delayed

 

Why Did Space Stocks Go Up When Artemis Kept Getting Delayed Is the Wrong Question

So here is the thing.

I kept staring at this one puzzle. NASA’s Artemis II got pushed back over and over. Hydrogen leaks. Helium flow problems. The whole rocket had to roll back to the building twice. The total program cost blew past $93 billion.

And yet. Space stocks kept climbing.

Rocket Lab went up over 1,500% in three years. Lockheed Martin jumped 38% just since January 2026. $55.3 billion poured into 431 space companies in one single year. A 65% increase.

That made no sense to me. Until I started pulling the threads.

Turns out the better question is not “why did stocks go up.” The better question is “what were those stocks actually tracking.”

The Delay Machine That Prints Money

Here is what I found when I followed the money instead of the headlines.

NASA runs on something called cost-plus contracts. That means when something breaks, when a fix takes longer, when a mission slides to the right on the calendar, the contractors get paid more. Not less. More.

Lockheed Martin builds the Orion capsule. Their space division pulled in $3.16 billion in Q4 2025 alone. Up 8% year over year. Their total backlog hit $194 billion. That is not a typo. $194 billion in future work already signed.

Northrop Grumman builds the HALO module for the lunar Gateway station. Their backlog reached $95.7 billion with a book-to-bill ratio of 1.10. Meaning they are winning contracts faster than they are finishing them.

So delays did not hurt these companies. Delays fed them.

That was the first piece.

The Bigger Picture Nobody Was Talking About

The second thing I noticed is that Artemis is not the whole story. Not even close.

While everyone was watching the Moon rocket sit on the pad, something much bigger was happening underneath.

Trump signed a “space superiority” executive order. Defense satellite spending surged. The Space Force budget for rapid launch alone hit $168 million for 2026. Musk and Bezos started racing to put AI data centers in orbit.

And then SpaceX confidentially filed for an IPO at a potential $1.75 trillion valuation. The day that news dropped, EchoStar jumped 40%. Rocket Lab jumped 35%. Redwire jumped 34%.

The logic was simple. If SpaceX is worth $1.75 trillion, then every publicly traded space company is probably underpriced.

Artemis was never the engine. It was just the most visible part of an ecosystem that was growing regardless.

Reuters confirmed it. Government defense spending plus private investment were both accelerating at the same time. The space market is $600 billion today. Projections say $1.8 trillion by 2035.

The Part That Made Me Nervous

Now here is where I have to be honest. Because not everything I found was comfortable.

When a stock goes up regardless of bad news, that can mean “the market sees deeper.” Or it can mean “the market is ignoring risk.”

Rocket Lab still burned $321.8 million in free cash flow in 2025. Their Neutron rocket failed a stage 1 tank test. BWXT trades at 57 times trailing earnings. Every time Artemis slipped, LUNR investors got tested.

So I ran competing scenarios.

About 70% of what I found points to structural growth. Space is not dependent on one mission anymore. Defense, AI, commercial launch, and satellite constellations are all growing independently.

About 20% points to overheating. If SpaceX delays its IPO or Neutron slips again, the air could come out fast.

About 10% is the wild card. If Congress cuts NASA’s budget or the Artemis program itself shrinks, the whole food chain feels it.

Morgan Stanley turned bullish on the sector for 2026. But even they flagged these risks.

What the People Who Actually Made Money Did

I dug into the actual playbooks. Not the theories. The moves.

They bought infrastructure, not rockets.

A firm called Balerion Space Ventures invested in orbital transfer vehicles, compact power systems, and ground station networks. Not the spacecraft. The stuff that makes spacecraft work. Same logic as investing in steel and telegraph lines during the railroad boom instead of buying the train.

For regular investors, this translates to ETFs like Procure Space ETF (UFO) or ARK Space and Defense Innovation ETF (ARKX) that spread across the ecosystem.

They bought the dip on delay days.

Rocket Lab traded at $4 to $5 during its 2021 SPAC listing. It hit $91 in January 2026. One investor wrote “I still cannot believe we were buying this stock at $4. I wish I had bought a lot more.”

Motley Fool labeled RKLB a “millionaire maker” based on three things. Neutron nearing commercialization. Backlog up 73% year over year to $1.85 billion. A perfect 100% launch success rate in 2025.

The pattern I noticed is that the people who made real money did not react to delay headlines. They checked whether the backlog was growing or shrinking. Growing backlog plus temporary price drop equals entry point. Shrinking backlog plus price drop equals real trouble.

They watched the backlog numbers, not the launch dates.

This is the table that changed how I look at this sector.

Lockheed Martin has $194 billion in backlog. All-time record. Guiding $77.5 to $80 billion in 2026 sales.

Northrop Grumman has $95.7 billion in backlog. Book-to-bill above 1.0. Guiding $43.5 to $44 billion.

Rocket Lab has $1.85 billion in backlog. Up 73% in one year. Wall Street expects revenue to double to $1.29 billion by 2027.

BWXT has $7.26 billion in backlog. Up 50%. Guiding $3.75 billion in 2026 revenue.

When the backlog is growing faster than revenue, the company has locked in future income even if the current mission is sitting on the pad going nowhere.

They positioned before catalysts, not after.

SpaceX IPO is expected around June 2026. Rocket Lab Neutron test flight is targeted for Q4 2026. Artemis III restructuring details are coming this year.

The investors who profited got in two to four weeks before these events. By the time the headline hits, the move has often already happened.

Three Things I Would Do With This Information

First. Stop watching the launch countdown. Start watching the backlog. That is where the money trail actually lives.

Second. Think ecosystem, not mission. One delayed rocket does not define a $600 billion industry heading toward $1.8 trillion. The investors building the infrastructure layer beneath Artemis are the ones shaping the next decade.

Third. Ask the uncomfortable question. Not “will this go up” but “what would have to go wrong for this to fall apart.” If SpaceX IPO stalls. If Neutron fails again. If the defense budget gets cut. Can your position survive that?

This whole sector reminds me of something.

The early railroads were chaos. Delays. Cost overruns. Explosions. People called them money pits. But the capital kept flowing because the infrastructure mattered more than any single train.

$55.3 billion flowed into space companies last year. That number was not driven by Artemis II launching on time. It was driven by the realization that space has become critical infrastructure for defense, communication, AI, and national security.

Artemis will probably get delayed again. The money will probably keep flowing anyway.

The people who figured that out early are the ones sitting on 1,500% gains right now.

  1. The Daily Rundown: When Will Artemis 2 Reach the Moon and What Smart Investors Found
  2. The Daily Rundown: Space Stocks After Artemis 2 Launch. Too Late or Still Early?
  3. The Daily Rundown: Artemis 3 Keeps Failing to Launch. Here Is Who Is Quietly Cashing In.


Q&A 

Q1: Why do space stocks go up when NASA Artemis missions get delayed? 

NASA operates on cost-plus contracts. When missions get delayed, contractors like Lockheed Martin and Northrop Grumman receive additional funding for repairs, inspections, and retesting. Delays also extend contract timelines, which means more revenue over a longer period. On top of that, the space economy is not dependent on a single mission. Defense satellites, commercial launches, and the SpaceX IPO have been driving the sector independently.


Q2: Which space stocks have gained the most despite Artemis delays? 

Rocket Lab (RKLB) rose over 1,500% in three years. Lockheed Martin climbed 38% year to date in early 2026. Northrop Grumman gained 65% over the past year. BWXT doubled. These gains were driven by record backlogs and expanding government and commercial contracts, not by Artemis launch dates.


Q3: Is it too late to invest in space stocks in 2026? 

The SpaceX IPO is expected around June 2026 and could reprice the entire sector upward. Rocket Lab's Neutron test flight is targeted for Q4 2026. However, valuations are elevated. Rocket Lab still burns over $300 million in free cash flow annually and some stocks trade at 50-plus times earnings. The opportunity is real but so is the risk of a correction if key catalysts disappoint.


Q4: What is the safest way to get exposure to space stocks without picking individual companies? 

Space-focused ETFs spread risk across the ecosystem. The Procure Space ETF (UFO) and ARK Space and Defense Innovation ETF (ARKX) hold diversified baskets of launch companies, satellite operators, defense contractors, and infrastructure providers. This mirrors the strategy of venture firms like Balerion Space Ventures that invest in the infrastructure layer rather than any single rocket or mission.


Q5: What is the one number I should watch to evaluate a space stock?

Backlog. When a company's backlog grows faster than its revenue, it means future income is already locked in regardless of whether the next mission launches on time. Lockheed Martin's $194 billion backlog, Northrop Grumman's $95.7 billion backlog, and Rocket Lab's 73% year-over-year backlog growth were the clearest signals that these stocks would hold up through delays.

No comments:

Post a Comment